Comparative Efficacies of Tedizolid Phosphate, Linezolid, and Vancomycin in a Murine Model of Subcutaneous Catheter-Related Biofilm Infection Due to Methicillin-Susceptible and -Resistant Staphylococcus aureus

被引：19
|
作者：
Bayer, Arnold S. [1 ,2 ]
Abdelhady, Wessam [1 ]
Li, Liang [1 ]
Gonzales, Rachelle [1 ]
Xiong, Yan Q. [1 ,2 ]
机构：
[1] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2016年 / 60卷 / 08期
关键词：
SKIN-STRUCTURE INFECTIONS; EXPERIMENTAL ENDOCARDITIS; MOUSE MODEL; OXAZOLIDINONE; ANTIBIOTICS; DAPTOMYCIN; TELAVANCIN; PNEUMONIA; MICE; RAT;
D O I：
10.1128/AAC.00880-16
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Tedizolid, a novel oxazolidinone, exhibits bacteriostatic activity through inhibition of protein synthesis. The efficacies of tedizolid, linezolid, and vancomycin were compared in a murine catheter-related biofilm infection caused by methicillin-susceptible and -resistant Staphylococcus aureus (MSSA and MRSA, respectively) strains engineered for bioluminescence. We observed significantly improved efficacy in terms of decreased S. aureus densities and bioluminescent signals in the tedizolid-treated group versus the linezolid-and vancomycin-treated groups in the model of infection caused by the MSSA and MRSA strains.
引用
收藏
页码：5092 / 5096
页数：5
相关论文
共 50 条
  • [31] Antimicrobial-Related Severe Adverse Events during Treatment of Bone and Joint Infection Due to Methicillin-Susceptible Staphylococcus aureus
    Valour, Florent
    Karsenty, Judith
    Bouaziz, Anissa
    Ader, Florence
    Tod, Michel
    Lustig, Sebastien
    Laurent, Frederic
    Ecochard, Rene
    Chidiac, Christian
    Ferry, Tristan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 746 - 755
  • [32] Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S-aureus?: A comparative cohort study of British patients with nosocomial infection and bacteremia
    Melzer, M
    Eykyn, SJ
    Gransden, WR
    Chinn, S
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (11) : 1453 - 1460
  • [33] Efficacy of Linezolid, Teicoplanin, and Vancomycin in Prevention of an Experimental Polytetrafluoroethylene Graft Infection Model caused by Methicillin-Resistant Staphylococcus aureus
    Mese, Bulent
    Bozoglan, Orhan
    Elveren, Serdal
    Eroglu, Erdinc
    Gul, Mustafa
    Celik, Ahmet
    Ciralik, Harun
    Yildirimdemir, Halil Ibrahim
    Yasim, Alptekin
    MEDICAL SCIENCE MONITOR, 2015, 21 : 909 - 914
  • [34] COMPARATIVE EFFICACIES OF CIPROFLOXACIN, PEFLOXACIN, AND VANCOMYCIN IN COMBINATION WITH RIFAMPIN IN A RAT MODEL OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS CHRONIC OSTEOMYELITIS
    DWORKIN, R
    MODIN, G
    KUNZ, S
    RICH, R
    ZAK, O
    SANDE, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) : 1014 - 1016
  • [35] In Vivo Activity of a Novel Anti-Methicillin-Resistant Staphylococcus aureus Cephalosporin, Ceftaroline, against Vancomycin-Susceptible and -Resistant Enterococcus faecalis Strains in a Rabbit Endocarditis Model: a Comparative Study with Linezolid and Vancomycin
    Jacqueline, Cedric
    Caillon, Jocelyne
    Le Mabecque, Virginie
    Miegeville, Anne-Francoise
    Ge, Yigong
    Biek, Donald
    Batard, Eric
    Potel, Gilles
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (12) : 5300 - 5302
  • [36] Comparison of antibiotic resistance, virulence gene profiles, and pathogenicity of methicillin-resistant and methicillin-susceptible Staphylococcus aureus using a Caenorhabditis elegans infection model
    Thompson, Terissa
    Brown, Paul D.
    PATHOGENS AND GLOBAL HEALTH, 2014, 108 (06) : 283 - 291
  • [37] In Vivo Pharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model
    Louie, Arnold
    Liu, Weiguo
    Kulawy, Robert
    Drusano, G. L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (07) : 3453 - 3460
  • [38] Comparative Efficacies of Cloxacillin-Daptomycin and the Standard Cloxacillin-Rifampin Therapies against an Experimental Foreign-Body Infection by Methicillin-Susceptible Staphylococcus aureus
    El Haj, Cristina
    Murillo, Oscar
    Ribera, Alba
    Vivas, Mireia
    Garcia-Somoza, Dolors
    Tubau, Fe
    Cabo, Javier
    Ariza, Javier
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5576 - 5580
  • [39] Comparative Efficacies of Human Simulated Exposures of Telavancin and Vancomycin against Methicillin-Resistant Staphylococcus aureus with a Range of Vancomycin MICs in a Murine Pneumonia Model (vol 54, pg 5115, 2010)
    Crandon, Jared L.
    Kuti, Joseph L.
    Nicolau, David P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (12)
  • [40] Impact of linezolid (LZD) and the vancomycin (VAN) on the production of cytokines and for the inflammatory of host response in a murine model of pneumonia Staphylococcus aureus resistant to methicillin (MRSA)
    Jacqueline, C.
    Broquet, A.
    Roquilly, A.
    Vourc'h, M.
    Potel, G.
    Caillon, J.
    Asehnoune, K.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2014, 33 : A222 - A223
12345